Insight

Namrata Vijayvergia: Can’t wait for Efrat Dotan’s presentation on GIANT study

Photo of Efrat Dotan from Fox Chase Cancer Center/X

Apr 28, 2024, 21:03

Namrata Vijayvergia: Can’t wait for Efrat Dotan’s presentation on GIANT study

Namrata Vijayvergia, GI Medical Oncologist at the Fox Chase Cancer Center, shared a post by Fox Chase Cancer Center, on X/Twitter, adding:

“Can’t wait for Efrat Dotan’s presentation on GIANT study focused on the vulnerable older pancreatic cancer patients at ASCO24.”

Quoting Fox Chase Cancer Center’s post:

“While the global population continues to age, there’s a significant gap in research focusing on cancer treatment for older adults. Dr. Efrat Dotan, Chief of Gastrointestinal Medical Oncology at Fox Chase, is dedicated to filling this void. Read more.”

Source: Namrata Vijayvergia/X and Fox Chase Cancer Center/X

ASCO24 cancer Efrat Dotan Fox Chase Cancer Center Gastrointestinal Medical Oncology GIANT study Namrata Vijayvergia OncoDaily Oncology Pancreatic Cancer

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage